Literature DB >> 27284093

Anticancer drugs during pregnancy.

Shingo Miyamoto1, Manabu Yamada2, Yasuyo Kasai2, Akito Miyauchi2, Kazumichi Andoh2.   

Abstract

Although cancer diagnoses during pregnancy are rare, they have been increasing with the rise in maternal age and are now a topic of international concern. In some cases, the administration of chemotherapy is unavoidable, though there is a relative paucity of evidence regarding the administration of anticancer drugs during pregnancy. As more cases have gradually accumulated and further research has been conducted, we are beginning to elucidate the appropriate timing for the administration of chemotherapy, the regimens that can be administered with relative safety, various drug options and the effects of these drugs on both the mother and fetus. However, new challenges have arisen, such as the effects of novel anticancer drugs and the desire to bear children during chemotherapy. In this review, we outline the effects of administering cytotoxic anticancer drugs and molecular targeted drugs to pregnant women on both the mother and fetus, as well as the issues regarding patients who desire to bear children while being treated with anticancer drugs.
© The Author 2016. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  anticancer drugs; malformation; pregnancy

Mesh:

Substances:

Year:  2016        PMID: 27284093     DOI: 10.1093/jjco/hyw073

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  1 in total

Review 1.  Management of urachal cancer in pregnancy: A systematic review.

Authors:  Kenneth K Y Chew; Samantha Quah; Madison R Boot; Steven Sowter
Journal:  BJUI Compass       Date:  2022-05-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.